Janus Henderson Group’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,226
| Closed | -$38.8K | – | 2586 |
|
|
2023
Q3 | $38.8K | Buy |
1,226
+1
| +0.1% | +$32 | ﹤0.01% | 2553 |
|
|
2023
Q2 | $101K | Sell |
1,225
-1
| -0.1% | -$82 | ﹤0.01% | 2566 |
|
|
2023
Q1 | $126K | Buy |
1,226
+772
| +170% | +$79.4K | ﹤0.01% | 2591 |
|
|
2022
Q4 | $66.5K | Sell |
454
-453
| -50% | -$66.4K | ﹤0.01% | 2396 |
|
|
2022
Q3 | $154K | Buy |
907
+453
| +100% | +$76.9K | ﹤0.01% | 2449 |
|
|
2022
Q2 | $53K | Buy |
454
+6
| +1% | +$700 | ﹤0.01% | 2547 |
|
|
2022
Q1 | $45K | Hold |
448
| – | – | ﹤0.01% | 2623 |
|
|
2021
Q4 | $70K | Buy |
+448
| New | +$70K | ﹤0.01% | 2523 |
|
|
2021
Q1 | – | Sell |
-36,764
| Closed | -$24.5M | – | 1605 |
|
|
2020
Q4 | $24.5M | Buy |
36,764
+410
| +1% | +$273K | 0.01% | 710 |
|
|
2020
Q3 | $16.9M | Buy |
36,354
+34,059
| +1,484% | +$15.9M | 0.01% | 744 |
|
|
2020
Q2 | $1.34M | Buy |
+2,295
| New | +$1.34M | ﹤0.01% | 1089 |
|